Similar directions of effect have been reported in a study by Dato et al. (64) in which a SNP in IP6K3 increased both lifespan and the risk of late-onset AD, while SNPs in IPMK and UCP4 genes were associated with a lower risk of both late-onset AD and shorter lifespan. The gene discussed is IP6K3; the disease is Onset.